Kristin leads the Diagnostics and Life Sciences Practice at Health Advances, a global practice which combines her consulting and scientific experience to provide results-oriented commercialization strategies for her clients in the pharmaceutical, life sciences, and clinical diagnostics sectors, including focus on launch strategy, pricing, and R&D prioritization for novel products for the research laboratory, personalized medicine, point-of-care, and mainstream clinical diagnostics. Kristin is a noted speaker, workshop leader and writer in the diagnostics and life sciences industries, covering topics such as the future of point-of-care platforms, the commercialization of companion diagnostics, and innovations in personalized medicine. Most recently, she worked with MassBio to develop its Personalized Medicine Year, is on the organizing committee for the Harvard Personalized Medicine Conference, was a judge for the Coulter Translational Research Awards, and is working with BIO to promote reimbursement reform for personalized medicine products. She is also a co-founder of Diagnostic Insights, an independent organization designed to educate on the impact of diagnostics in improving health care outcomes to the nation's healthcare communities.

Kristin has over 16 years of experience in the diagnostics and drug discovery industries. Prior to joining Health Advances in 2002, Kristin was a scientist in diagnostics technology development at Genzyme and genomics research at Genome Therapeutics. She has an undergraduate degree in Biochemistry from Smith College and a Masters degree in Epidemiology, Health Management, and Maternal and Child Health from the Harvard School of Public Health.